Cifuentes E, Trasande L, Ramirez M, Landrigan PJ A qualitative analysis of environmental policy and children's health in Mexico. Environ Health. 2010 Mar 23;9:14. doi: 10.1186/1476-069X-9-14. Review.
Cuffe KM, Newton-Levinson A, Gift TL, McFarlane M, Leichliter JS Sexually Transmitted Infection Testing Among Adolescents and Young Adults in the United States. J Adolesc Health. 2016 May;58(5):512-9. doi: 10.1016/j.jadohealth.2016.01.002. Epub 2016 Mar 15.
Friedman AL, Kachur RE, Noar SM, McFarlane M Health Communication and Social Marketing Campaigns for Sexually Transmitted Disease Prevention and Control: What Is the Evidence of their Effectiveness? Sex Transm Dis. 2016 Feb;43(2 Suppl 1):S83-101. doi: 10.1097/OLQ.0000000000000286. Review.
Goyal MK, Teach SJ, Badolato GM, Trent M, Chamberlain JM Universal Screening for Sexually Transmitted Infections among Asymptomatic Adolescents in an Urban Emergency Department: High Acceptance but Low Prevalence of Infection. J Pediatr. 2016 Apr;171:128-32. doi: 10.1016/j.jpeds.2016.01.019. Epub 2016 Feb 2.
Pearson WS, Peterman TA, Gift TL An increase in sexually transmitted infections seen in US emergency departments. Prev Med. 2017 Jul;100:143-144. doi: 10.1016/j.ypmed.2017.04.028. Epub 2017 Apr 26.
Uken RB, Brummer O, von Schubert-Bayer C, Brodegger T, Teudt IU Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study. Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1933-42. doi: 10.1007/s00405-016-3953-1. Epub 2016 Mar 9.
Sexual Behavior: Challenges in Prevention and Control Among Medical Students in Mexico
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
